Exploring the Use of GLP-1 RAs in T2DM is organized by Pri-Med.
Release Date: 08/15/2023
Expiration Date: 08/15/2024
Description:
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) play an important role in the guideline-driven, patient-centered management of type 2 diabetes mellitus (T2DM). This adaptive learning activity will cover high-yield topics pertaining to GLP-1 RAs, including the pharmacology of GLP-1 RAs and the updated American Diabetes Association guidelines for treating T2DM.
Learning Objectives:
• Explore the similarities and differences among the available glucagon-like peptide-1 receptor agonists (GLP-1 RAs)
• Discuss the prominent role of evidence-based GLP-1 RAs in recent clinical practice guidelines